More interestingly, our cell–cell binding assays demonstrated that aberrant expression of VCAM-1 on PDAC cells might tethers monocytes to cancer cells through counter–receptor interactions, providing a survival advantage to PDAC cells that infiltrate leukocyte-rich microenvironments. The gene discussed is VCAM1; the disease is cancer.